Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma

N. Yamazaki, Y. Kiyohara, H. Uhara, S. Fukushima, H. Uchi, N. Shibagaki, A. Tsutsumida, S. Yoshikawa, R. Okuyama, Y. Ito, T. Tokudome

Research output: Contribution to journalArticle

45 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds